Wall St Price Targets

SBC Price Forecast
Based on 17 analysts

+13% Upside
from €17.46 today

Sabra Health Care REIT Inc (SBC)’s 12-month stock price forecast through October 2027 has a consensus target of €19.71, implying 13% upside. The forecast is based on price targets from 17 Wall Street analysts.

SBC Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for SBC yet.

Sabra Health Care REIT Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SBC's stock price target?
Price Target
19.71 EUR

According to Wall Street analysts, the average 1-year price target for SBC is 19.71 EUR with a low forecast of 16.86 EUR and a high forecast of 23.06 EUR.

What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.

What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.

What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.

What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.

Back to Top